Keruly JC - Search Results

1

Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.

Moore RD, Keruly JC, Chaisson RE. Moore RD, et al. Among authors: keruly jc. J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):46-51. doi: 10.1097/00126334-200401010-00006. J Acquir Immune Defic Syndr. 2004. PMID: 14707791

2

Association of medical insurance and other factors with receipt of antiretroviral therapy.

Keruly JC, Conviser R, Moore RD. Keruly JC, et al. Am J Public Health. 2002 May;92(5):852-7. doi: 10.2105/ajph.92.5.852. Am J Public Health. 2002. PMID: 11988459 Free PMC article.

3

Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection.

Gebo KA, Gallant JE, Keruly JC, Moore RD. Gebo KA, et al. Among authors: keruly jc. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1028-33. doi: 10.1097/00126334-200408150-00005. J Acquir Immune Defic Syndr. 2004. PMID: 15247555

4

Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.

Gallant JE, Parish MA, Keruly JC, Moore RD. Gallant JE, et al. Among authors: keruly jc. Clin Infect Dis. 2005 Apr 15;40(8):1194-8. doi: 10.1086/428840. Epub 2005 Mar 17. Clin Infect Dis. 2005. PMID: 15791522 Clinical Trial.

5

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002.

Moore RD, Keruly JC, Gebo KA, Lucas GM. Moore RD, et al. Among authors: keruly jc. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):195-8. J Acquir Immune Defic Syndr. 2005. PMID: 15905736

6

Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.

Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Barry PM, et al. Among authors: keruly jc. AIDS. 2006 Feb 14;20(3):437-44. doi: 10.1097/01.aids.0000206507.54901.84. AIDS. 2006. PMID: 16439878

7

Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care.

Brock MV, Hooker CM, Engels EA, Moore RD, Gillison ML, Alberg AJ, Keruly JC, Yang SC, Heitmiller RF, Baylin SB, Herman JG, Brahmer JR. Brock MV, et al. Among authors: keruly jc. J Acquir Immune Defic Syndr. 2006 Sep;43(1):47-55. doi: 10.1097/01.qai.0000232260.95288.93. J Acquir Immune Defic Syndr. 2006. PMID: 16936558

8

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

Moore RD, Keruly JC. Moore RD, et al. Among authors: keruly jc. Clin Infect Dis. 2007 Feb 1;44(3):441-6. doi: 10.1086/510746. Epub 2006 Dec 20. Clin Infect Dis. 2007. PMID: 17205456

9

Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.

Grinsztejn B, Veloso VG, Pilotto JH, Campos DP, Keruly JC, Moore RD. Grinsztejn B, et al. Among authors: keruly jc. J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):515-20. doi: 10.1097/QAI.0b013e3180decb6a. J Acquir Immune Defic Syndr. 2007. PMID: 17558332

10

Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.

Keruly JC, Moore RD. Keruly JC, et al. Clin Infect Dis. 2007 Nov 15;45(10):1369-74. doi: 10.1086/522759. Epub 2007 Oct 11. Clin Infect Dis. 2007. PMID: 17968837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters